417 related articles for article (PubMed ID: 28126818)
21. Anti-dengue virus nonstructural protein 1 antibodies contribute to platelet phagocytosis by macrophages.
Wan SW; Yang YW; Chu YT; Lin CF; Chang CP; Yeh TM; Anderson R; Lin YS
Thromb Haemost; 2016 Mar; 115(3):646-56. PubMed ID: 26632672
[TBL] [Abstract][Full Text] [Related]
22. Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.
Simmons M; Putnak R; Sun P; Burgess T; Marasco WA
Am J Trop Med Hyg; 2016 Nov; 95(5):1148-1156. PubMed ID: 27645784
[TBL] [Abstract][Full Text] [Related]
23. Oxidative stress in severe dengue viral infection: association of thrombocytopenia with lipid peroxidation.
Soundravally R; Sankar P; Bobby Z; Hoti SL
Platelets; 2008 Sep; 19(6):447-54. PubMed ID: 18925513
[TBL] [Abstract][Full Text] [Related]
24. Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains.
Puerta-Guardo H; Mosso C; Medina F; Liprandi F; Ludert JE; del Angel RM
J Gen Virol; 2010 Feb; 91(Pt 2):394-403. PubMed ID: 19828759
[TBL] [Abstract][Full Text] [Related]
25. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).
Pang T; Cardosa MJ; Guzman MG
Immunol Cell Biol; 2007 Jan; 85(1):43-5. PubMed ID: 17130899
[TBL] [Abstract][Full Text] [Related]
26. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.
Guzman MG; Alvarez M; Halstead SB
Arch Virol; 2013 Jul; 158(7):1445-59. PubMed ID: 23471635
[TBL] [Abstract][Full Text] [Related]
27. Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity.
Thein S; Aaskov J; Myint TT; Shwe TN; Saw TT; Zaw A
J Med Virol; 1993 Jun; 40(2):102-6. PubMed ID: 8360631
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection.
Moi ML; Lim CK; Takasaki T; Kurane I
J Gen Virol; 2010 Jan; 91(Pt 1):103-11. PubMed ID: 19776239
[TBL] [Abstract][Full Text] [Related]
29. Serum nitric oxide in children with dengue infection.
Trairatvorakul P; Chongsrisawat V; Ngamvasinont D; Asawarachun D; Nantasook J; Poovorawan Y
Asian Pac J Allergy Immunol; 2005; 23(2-3):115-9. PubMed ID: 16252841
[TBL] [Abstract][Full Text] [Related]
30. Dengue Virus Nonstructural Protein 1-Induced Antibodies Cross-React with Human Plasminogen and Enhance Its Activation.
Chuang YC; Lin J; Lin YS; Wang S; Yeh TM
J Immunol; 2016 Feb; 196(3):1218-26. PubMed ID: 26712948
[TBL] [Abstract][Full Text] [Related]
31. Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection.
Branche E; Tang WW; Viramontes KM; Young MP; Sheets N; Joo Y; Nguyen AT; Shresta S
Antiviral Res; 2018 Oct; 158():1-7. PubMed ID: 30071205
[TBL] [Abstract][Full Text] [Related]
32. Antibodies against thrombin in dengue patients contain both anti-thrombotic and pro-fibrinolytic activities.
Chuang YC; Lin YS; Liu HS; Wang JR; Yeh TM
Thromb Haemost; 2013 Aug; 110(2):358-65. PubMed ID: 23740201
[TBL] [Abstract][Full Text] [Related]
33. Dengue virus and antiplatelet autoantibodies synergistically induce haemorrhage through Nlrp3-inflammasome and FcγRIII.
Lien TS; Sun DS; Chang CM; Wu CY; Dai MS; Chan H; Wu WS; Su SH; Lin YY; Chang HH
Thromb Haemost; 2015 May; 113(5):1060-70. PubMed ID: 25740324
[TBL] [Abstract][Full Text] [Related]
34. Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants.
Adimy M; Mancera PFA; Rodrigues DS; Santos FLP; Ferreira CP
Bull Math Biol; 2020 Jan; 82(2):24. PubMed ID: 31993759
[TBL] [Abstract][Full Text] [Related]
35. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.
Mady BJ; Erbe DV; Kurane I; Fanger MW; Ennis FA
J Immunol; 1991 Nov; 147(9):3139-44. PubMed ID: 1680925
[TBL] [Abstract][Full Text] [Related]
36. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.
Noisakran S; Perng GC
Exp Biol Med (Maywood); 2008 Apr; 233(4):401-8. PubMed ID: 18367628
[TBL] [Abstract][Full Text] [Related]
37. Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection.
Mady BJ; Kurane I; Erbe DV; Fanger MW; Ennis FA
J Gen Virol; 1993 May; 74 ( Pt 5)():839-44. PubMed ID: 8492089
[TBL] [Abstract][Full Text] [Related]
38. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.
Littaua R; Kurane I; Ennis FA
J Immunol; 1990 Apr; 144(8):3183-6. PubMed ID: 2139079
[TBL] [Abstract][Full Text] [Related]
39. Relative Contribution of Dengue IgG Antibodies Acquired during Gestation or Breastfeeding in Mediating Dengue Disease Enhancement and Protection in Type I Interferon Receptor-Deficient Mice.
Lee PX; Ong LC; Libau EA; Alonso S
PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004805. PubMed ID: 27341339
[TBL] [Abstract][Full Text] [Related]
40. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
